CI
INVA icon

CX Institutional’s Innoviva INVA Stock Holding History

CX Institutional’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.36M Buy
280,240
+2,708
+1% +$62K 0.18% 135
2026
Q1 		$6.47M Buy
+277,532
New +$5.98M 0.2% 119

Other funds holding INVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

CX Institutional's INVA Position: Q2 2026 in Review

CX Institutional increased its Innoviva (INVA) stake by 0.98% in Q2 2026, buying an estimated $62K and bringing the position to 280,240 shares worth $6.36M. The position accounts for 0.18% of the portfolio, ranked #135.

CX Institutional first reported a position in INVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.47M in Q1 2026. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • CX Institutional held 280,240 shares of Innoviva worth $6.36M as of Q2 2026.
  • CX Institutional bought 2,708 Innoviva shares in Q2 2026, an estimated $62K.
  • Innoviva made up 0.18% of CX Institutional's portfolio in Q2 2026, its #135 holding.
  • CX Institutional first reported a position in Innoviva in Q1 2026 and has held it in 2 quarters since.
  • CX Institutional's Innoviva position peaked at $6.47M in Q1 2026.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.